ATE237360T1 - Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation - Google Patents

Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation

Info

Publication number: ATE237360T1
Authority: AT; Austria
Prior art keywords: relating; regulation; cell activation; subject; cell
Prior art date: 1997-09-06

Application number

AT98940480T

Other languages

English (en)

Inventor

Luis Alvarez-Vallina

Stephen James Russell

Robert Hawkins

Siamak Agha-Mohammadi

Original Assignee

Mayo Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-06

Filing date

1998-09-07

Publication date

2003-05-15

1997-09-06 Priority claimed from GBGB9718872.6A external-priority patent/GB9718872D0/en

1998-09-07 Application filed by Mayo Foundation filed Critical Mayo Foundation

2003-05-15 Application granted granted Critical

2003-05-15 Publication of ATE237360T1 publication Critical patent/ATE237360T1/de

Links

230000019908 regulation of T cell activation Effects 0.000 title 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
230000002163 immunogen Effects 0.000 abstract 2
150000007523 nucleic acids Chemical group 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
230000001105 regulatory effect Effects 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Hematology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cell Biology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

AT98940480T 1997-09-06 1998-09-07 Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation ATE237360T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB9718872.6A GB9718872D0 (en)	1997-09-06	1997-09-06	Improvements in or relating to expression of immunogenic substances
GBGB9723448.8A GB9723448D0 (en)	1997-09-06	1997-11-07	Improvements in or relating to expression of immunogenic substances
US7644898P	1998-03-02	1998-03-02
PCT/GB1998/002689 WO1999012573A1 (en)	1997-09-06	1998-09-07	Improvements in or relating to regulation of t cell activation

Publications (1)

Publication Number	Publication Date
ATE237360T1 true ATE237360T1 (de)	2003-05-15

Family

ID=27269003

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98940480T ATE237360T1 (de)	1997-09-06	1998-09-07	Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation

Country Status (7)

Country	Link
EP (2)	EP1009442B1 (de)
JP (2)	JP2001515873A (de)
AT (1)	ATE237360T1 (de)
AU (2)	AU747045B2 (de)
CA (2)	CA2303617A1 (de)
DE (1)	DE69813573T2 (de)
WO (2)	WO1999012573A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5589362A (en) *	1993-06-14	1996-12-31	Basf Aktiengesellschaft	Tetracycline regulated transcriptional modulators with altered DNA binding specificities

1998
- 1998-09-07 JP JP2000510470A patent/JP2001515873A/ja not_active Withdrawn
- 1998-09-07 DE DE69813573T patent/DE69813573T2/de not_active Expired - Fee Related
- 1998-09-07 CA CA002303617A patent/CA2303617A1/en not_active Abandoned
- 1998-09-07 CA CA002303618A patent/CA2303618A1/en not_active Abandoned
- 1998-09-07 AT AT98940480T patent/ATE237360T1/de not_active IP Right Cessation
- 1998-09-07 AU AU89926/98A patent/AU747045B2/en not_active Ceased
- 1998-09-07 AU AU88799/98A patent/AU734877B2/en not_active Ceased
- 1998-09-07 WO PCT/GB1998/002689 patent/WO1999012573A1/en not_active Ceased
- 1998-09-07 EP EP98940480A patent/EP1009442B1/de not_active Expired - Lifetime
- 1998-09-07 EP EP98941611A patent/EP1015036A1/de not_active Withdrawn
- 1998-09-07 JP JP2000510471A patent/JP2001515709A/ja not_active Withdrawn
- 1998-09-07 WO PCT/GB1998/002693 patent/WO1999012574A1/en not_active Ceased

Also Published As

Publication number	Publication date
EP1009442B1 (de)	2003-04-16
WO1999012573A1 (en)	1999-03-18
AU734877B2 (en)	2001-06-21
AU747045B2 (en)	2002-05-09
WO1999012574A1 (en)	1999-03-18
AU8879998A (en)	1999-03-29
CA2303617A1 (en)	1999-03-18
EP1015036A1 (de)	2000-07-05
JP2001515873A (ja)	2001-09-25
DE69813573D1 (de)	2003-05-22
EP1009442A1 (de)	2000-06-21
AU8992698A (en)	1999-03-29
JP2001515709A (ja)	2001-09-25
DE69813573T2 (de)	2004-02-26
CA2303618A1 (en)	1999-03-18

Similar Documents

Publication	Publication Date	Title
IL118201A0 (en)	1996-09-12	Erythropoietin free of animal proteins processes for production and use thereof
ATE319827T1 (de)	2006-03-15	Polypeptid, das die differenzierung unterdrueckt
DK0559884T4 (da)	2004-08-02	Rekombinante virusvektorer til ekspression i muskelceller
ES2046462T3 (es)	1994-02-01	Marcadores de activacion de celulas "t".
DE69334257D1 (de)	2009-02-26	Methode zur Einführung von genetischem Material in Zellen
ES2185695T3 (es)	2003-05-01	Terapia genica dirigida.
DK0400958T3 (da)	1996-01-15	Levende vacciner
ATE100858T1 (de)	1994-02-15	Pflanzengewebe-transformation.
DE3650751D1 (de)	2001-02-22	Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung
ATE69241T1 (de)	1991-11-15	Herstellung von polypeptiden mit humangammainterferon-aktivitaet.
DK215287D0 (da)	1987-04-28	Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
BR9712556A (pt)	1999-10-19	Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno
DE3576361D1 (de)	1990-04-12	Rekombinante dna, damit transformierter mikroorganismus, und verfahren zur herstellung von menschlicher cu-zn superoxiddismutase unter verwendung des transformierten mikroorganismus.
KR870700373A (ko)	1987-12-28	동전학적 의약투여 속도를 제어하는 시스텝 및 방법
ES2078243T3 (es)	1995-12-16	Mejoras en o relativas a la expresion eucariotica.
ATE237360T1 (de)	2003-05-15	Verbesserungen der oder in bezug auf die regulierung der t-zellaktivation
EP0315118A3 (de)	1990-09-19	Endothelin kodierendes DNA und dessen Verwendung
NO873437D0 (no)	1987-08-14	Human placenta angiogen faktor i stand til aa stimulere kapillaer endotelcelle-proteasesyntese, dna-syntese og migrasjon.
DE69433902D1 (de)	2004-08-19	Neuartige tyrosinkinase
HUP0001057A2 (hu)	2000-08-28	A szarvasmarhafélék laktációjával összefüggő fehérje (CD14), az azt kódoló gén és a fehérje B-sejt-aktiválásban való alkalmazása
ATE346863T1 (de)	2006-12-15	Verwendung von eif4e-bindungsreagenzien in der therapie
JPS6480298A (en)	1989-03-27	Production of human proapolipoprotein a-i-like protein
AR242636A1 (es)	1994-09-30	Gen con codificacion para actividad de factor estimulante de colonias de granulocitos humanos.
Lorenz	1985	West Germany: science and animal protection
RU97102947A (ru)	1999-02-27	Способ лечения диффузного токсического зоба

Legal Events

Date	Code	Title	Description
2003-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties